A microassay for quantitatively detecting the Epstein-Barr virus receptor on single cells utilizing flow cytometry

Area of Science:

• Virology
• Cell Biology
• Immunology

Background:

• The Epstein-Barr virus (EBV) receptor (EBVR) plays a crucial role in EBV infection.
• Accurate quantification of EBVR is essential for understanding viral tropism and pathogenesis.
• Existing methods for EBVR detection may lack precision or substrain specificity.

Purpose of the Study:

• To develop and validate a quantitative microassay for detecting and analyzing the Epstein-Barr virus receptor (EBVR).
• To assess the virus substrain specificity of the developed assay.
• To correlate EBVR expression with cellular characteristics like cell size and DNA content.

Main Methods:

• Development of a quantitative microassay using fluorescein-conjugated Epstein-Barr virus (EBV) virions.
• Application of the assay to B95-8 and P3HR-1 EBV substrains.
• Assessment of relative virus binding using flow cytometry.
• Simultaneous measurement of cell size and cellular DNA content alongside virus binding.

Main Results:

• The microassay provides quantitative detection and analysis of EBVR.
• The assay demonstrates specificity for different EBV substrains (B95-8 and P3HR-1).
• Flow cytometry results are comparable to earlier detection methods.
• Simultaneous measurements enabled calculation of EBVR density and correlation with cell cycle stage.

Conclusions:

• The developed fluorescein-conjugated virion microassay is a reliable tool for quantitative EBVR analysis.
• This assay allows for substrain-specific detection and provides insights into EBVR regulation during the cell cycle.
• The method facilitates a deeper understanding of EBV-host cell interactions.